Induction of apoptosis by chemotherapeutic drugs: The role of FADD in activation of caspase-8 and synergy with death receptor ligands in ovarian carcinoma cells

被引：0

作者：

Milner A.E. ^{[1
]}

Palmer D.H. ^{[1
]}

Hodgkin E.A. ^{[1
]}

Eliopoulos A.G. ^{[1
]}

Knox P.G. ^{[1
]}

Poole C.J. ^{[1
]}

Kerr D.J. ^{[1
]}

Young L.S. ^{[1
]}

机构：

[1] CRC Institute for Cancer Studies, Clinical Research Block, University of Birmingham

来源：

Cell Death & Differentiation | 2002年 / 9卷 / 3期

基金：

英国医学研究理事会;

关键词：

Adenovirus; Apoptosis; Death receptors; Drug resistance; Ovarian carcinoma;

D O I：

10.1038/sj.cdd.4400945

中图分类号：

学科分类号：

摘要：

Although ovarian tumours initially respond to chemotherapy, they gradually acquire drug resistance. The aims of this study were to identify how chemotherapeutic drugs with diverse cellular targets activate apoptotic pathways and to investigate the mechanism by which exposure to a combination of drugs plus death receptor ligands can increase tumour cell kill. The results show that drugs with distinct cellular targets differentially up-regulate TRAIL and TNF as well CD95L, but do not require interaction of these ligands with their receptor partners to induce cell death. Factors that were critical in drug-induced apoptosis were activation of caspases, with caspase-8 being activated by diverse drugs in a FADD-independent manner. Certain drugs also demonstrated some dependence on FADD in the induction of cell death. Caspase-9 was activated more selectively by chemotherapeutic agents. Combining ligation of death receptors with exposure to drugs increased tumour cell kill in both drug resistant cell lines and primary ovarian carcinoma cells, even though these cells were not sensitive to death receptor ligation alone. CD95L was more consistent at combining with drugs than TRAIL or TNF. Investigation of the mechanism by which a combination of drugs plus CD95 ligation can increase cell death showed that caspase-8 was activated in cells exposed to a combination of cisplatin and anti-CD95, but not in cells exposed to either agent alone.

引用

页码：287 / 300

页数：13

共 44 条

[21]

Tolis C., Peters G.J., Ferreira C.G., Pinedo H.M., Giaccone G., Cell cycle disturbances and apoptosis induced by topotecan and gemcitabine on human lung cancer cell lines, Eur. J. Cancer, 35, pp. 796-807, (1999)

[22]

Wang S.J., Wang Z.L., Boise L., Dent P., Grant S., Loss of the Bcl-2 phosphorylation loop domain increases resistance of human leukemia cells (U937) to paclitaxel-mediated mitochondrial dysfunction and apoptosis, Biochem. Biophys. Res. Commun., 259, pp. 67-72, (1999)

[23]

Morimoto H., Yonehara S., Bonavida B., Overcoming TNF and drug resistance of human tumour cell lines by combination treatment with anti-Fas antibody and drugs or toxins, Cancer Res., 53, pp. 2591-2596, (1993)

[24]

Nakamura S., Takeshima M., Nakamura Y., Ohtake S., Matsuda T., Induction of apoptosis in HL60 leukaemic cells by anticancer drugs in combination with anti-Fas monoclonal antibody, Anticancer Res., 17, pp. 173-180, (1997)

[25]

Mizutani Y., Okada Y., Yoshida O., Fukumoto M., Bonavida B., Doxorubicin sensitises human bladder carcinoma cells to Fas-mediated cytotoxicity, Cancer, 79, pp. 1180-1189, (1997)

[26]

Alexander R.B., Nelson W.G., Coffey D.S., Synergistic enhancement by TNF of in vitro cytotoxicity from chemotherapeutic drugs targeted at DNA topoisomerase II, Cancer Res., 47, pp. 2403-2406, (1987)

[27]

Keane M.M., Ettenberg S.A., Nau M.M., Russell E.K., Lipowitz S., Chemotherapy augments TRAIL-induced apoptosis in breast cell lines, Cancer Res., 59, pp. 734-741, (1999)

[28]

Posovsky C., Friesen C., Herr I., Debatin K.-M., Chemotherapeutic drugs sensitise pre-ALL cells for CD95- and cytotoxic T-lymphocyte-mediated apoptosis, Leukaemia, 13, pp. 400-409, (1999)

[29]

Ogasawara J., Watanabe-Fukunage R., Adachi M., Matsuzawa A., Kasugai T., Kitamura Y., Itoh N., Suda T., Nagata S., Lethal effect of the anti-Fas antibody in mice, Nature, 364, pp. 806-809, (1993)

[30]

Wesselborg S., Engels I.H., Rossman E., Los M., Schulze-Osthoff K., Anticancer drugs induce Caspase-8 activation and apoptosis in the absence of CD95 receptor/ligand interaction, Blood, 93, pp. 3053-3063, (1999)

← 1 2 3 4 5 →